Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Wednesday, July 8, 2026
🇪🇺 EMA

mavorixafor News

🇪🇺 EMA ← All news

EMA mavorixafor coverage for business development, investment, and market access teams

High impact NewsJun 3, 2026

X4 Pharmaceuticals Secures Positive EMA CHMP Opinion for Mavorixafor in WHIM Syndrome

FDA · WHIM Syndrome · 5 min

Dr. Elena Rossi
Critical impact NewsApr 29, 2026

Norgine Receives European Commission Approval for XOLREMDI (Mavorixafor) as First WHIM Syndrome Treatment

Primary Immunodeficiency - WHIM Syndrome · 3 min

Dr. Hannah O'Connor

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.